These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30600674)

  • 41. Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions?
    Lytras D; Kalaitzakis E; Webster GJ; Imber CJ; Amin Z; Rodriguez-Justo M; Pereira SP; Olde Damink SW; Malagoʼ M
    Ann Surg; 2012 Dec; 256(6):1059-67. PubMed ID: 22580936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
    Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
    Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
    Plentz RR; Malek NP
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surveillance of Populations at Risk of Cholangiocarcinoma Development in Rural Communities of Thailand Using the Korat-CCA Verbal Screening Test.
    Kaewpitoon SJ; Rujirakul R; Loyd RA; Panpimanmas S; Matrakool L; Tongtawee T; Kompor P; Norkaew J; Chavengkun W; Wakkhuwattapong P; Kujapun J; Ponphimai S; Phatisena T; Eaksunti T; Polsripradist P; Joosiri A; Sukkasam I; Padchasuwan N; Kaewpitoon N
    Asian Pac J Cancer Prev; 2016; 17(4):2205-9. PubMed ID: 27221919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endoscopic retrograde cholangiopancreatography and endoscopic papillotomy in recurrent pyogenic cholangitis.
    Choi TK; Wong J
    Clin Gastroenterol; 1986 Apr; 15(2):393-415. PubMed ID: 3731519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.
    Al Mamari S; Djordjevic J; Halliday JS; Chapman RW
    J Hepatol; 2013 Feb; 58(2):329-34. PubMed ID: 23085647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholangiocarcinoma: expanding the spectrum of risk factors.
    Elfaki DH; Gossard AA; Lindor KD
    J Gastrointest Cancer; 2008; 39(1-4):114-7. PubMed ID: 19142590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
    Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
    Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
    World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cholangiocarcinoma due to postradiation therapy cholangitis and chronic pancreatitis].
    Rebours V; Lévy P; Hammel P; Farges O; Ruszniewski P
    Gastroenterol Clin Biol; 2005; 29(6-7):732-4. PubMed ID: 16142009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia.
    Boyd S; Tenca A; Jokelainen K; Mustonen H; Krogerus L; Arola J; Färkkilä MA
    Endoscopy; 2016 May; 48(5):432-9. PubMed ID: 26808393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monolobar Caroli's Disease and cholangiocarcinoma.
    Abdalla EK; Forsmark CE; Lauwers GY; Vauthey JN
    HPB Surg; 1999; 11(4):271-6; discussion 276-7. PubMed ID: 10468120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Taghavi SA; Eshraghian A; Niknam R; Sivandzadeh GR; Bagheri Lankarani K
    Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver transplantation for intrahepatic cholangiocarcinoma.
    Lee DD; Croome KP; Musto KR; Melendez J; Tranesh G; Nakhleh R; Taner CB; Nguyen JH; Patel T; Harnois DM
    Liver Transpl; 2018 May; 24(5):634-644. PubMed ID: 29514406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
    Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality.
    Sano T; Shimada K; Sakamoto Y; Yamamoto J; Yamasaki S; Kosuge T
    Ann Surg; 2006 Aug; 244(2):240-7. PubMed ID: 16858186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biliary cystadenocarcinoma associated with atrophy of the left hepatic lobe and hepatolithiasis mimicking intrahepatic cholangiocarcinoma: a case report.
    Tseng CA; Pan YS; Chen CY; Liu CS; Wu DC; Wang WM; Jan CM
    Kaohsiung J Med Sci; 2004 Apr; 20(4):198-203. PubMed ID: 15191223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.